Peripheral Nerve Block Clinical Trial
Official title:
Local Anesthetic Concentration and Nerve Block Duration: A Randomized, Blinded Study in Healthy Volunteers
Background: Local anesthetic (LA) concentration and nerve block duration is sparsely
described in a heterogenic study mass.
Aim: To investigate the effect of LA concentration on peripheral nerve block duration in
healthy volunteers.
Methods: Randomization of 60 healthy volunteers who will receive 1 of 5 different volumes of
LA (ropivacaine) using a constant dose.
Primary endpoint: Sensory nerve block defined by insensitivity towards cold.
Background:
Important factors for a safe and successful nerve block include volume, dose and
concentration of local anesthetic (LA). Knowing the duration of peripheral nerve blocks is
important to prevent pain breakthrough. With the advancements in ultrasound (US)-guided nerve
block techniques it has been possible to substantially reduce the amount of LA required to
perform a successful nerve block. This has reduced the risk of systemic toxicity. However,
lowering LA volume may reduce nerve block duration, but the extent of this is sparsely
described in a heterogenic study mass.
Diluted and large volumes of LA seem to correlate with nerve block duration. Furthermore,
increasing LA concentration seems to increase the level of motor block, but not the block
duration. A long-lasting nerve block without dense motor block is preferable for optimized
pain control and better opportunities to rehabilitate/ambulate.
Aim:
To investigate the effect of LA concentration on common peroneal nerve block duration in
healthy volunteers.
Methods:
Randomization of 60 healthy volunteers who will receive 1 of 5 different volumes of LA
(ropivacaine) using a constant dose (10mg).
Primary outcome: Duration of sensory nerve block defined by insensitivity towards cold.
Secondary outcome: Duration of motor nerve block defined by either paresis or paralysis.
Explorative outcomes: Degrees of sensory and motor nerve block; Onset times of sensory and
motor nerve block; Length of neural exposure to LA.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05610969 -
Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03628040 -
Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery
|
Phase 3 | |
Not yet recruiting |
NCT02576015 -
The Effect of Continuous Femoral Nerve Block With Modulation of Depth of Anesthesia on Prognosis of Patients Receiving Total Knee Arthroplasty
|
N/A | |
Completed |
NCT02374008 -
The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty.
|
Phase 4 | |
Withdrawn |
NCT01625208 -
Supraclavicular Versus Combined Block for Ulnar and Median Distribution Hand Surgery
|
N/A | |
Completed |
NCT06155903 -
Peripheral Nerve Block vs Spinal Anesthesia in Patients With Femur Fracture
|
N/A | |
Terminated |
NCT05190302 -
Determination of the Sensitivity, Specificity & Receiver Operating Characteristic of Nerve Stimulation Receptor as a Decision-making Tool During US Guided PNB
|
||
Terminated |
NCT02161484 -
Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement
|
N/A | |
Active, not recruiting |
NCT06357013 -
Postoperative Analgesia in Bilateral Knee Arthroplasties
|
||
Recruiting |
NCT06267716 -
Pericapsular Nerve Block and Iliopsoas Fascial Plane Block in Hip Surgery
|
N/A | |
Withdrawn |
NCT04539730 -
Liposomal Bupivacaine in Adductor Canal Blocks (ACB)
|
Phase 4 | |
Withdrawn |
NCT03385967 -
Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block
|
Phase 4 | |
Completed |
NCT03069677 -
Music vs Midazolam During Preop Nerve Block Placement
|
Phase 3 | |
Completed |
NCT04294732 -
Efficacy of Popliteal Block and Bupivacaine Concentration Used for Analgesia in Foot and Ankle Surgery
|
Phase 4 |